| 2014-03-04 | Precigen, Inc. PGEN | SVP--Health Sector | 116,000 0.1256% | $26.04 | $3.02M | -8.59% | ||
| 2014-03-03 | Precigen, Inc. PGEN | SVP--Health Sector | 7,000 0.0075% | $24.59 | $172,103 | -4.35% | ||
| 2014-02-28 | Precigen, Inc. PGEN | SVP--Health Sector | 77,000 0.0827% | $25.93 | $2M | -8.93% | ||
| 2012-08-13 | Halozyme Therapeutics, Inc. HALO | CEO, President | 2,000 0.0017% | $5.50 | $11,000 | +10.39% | ||
| 2011-08-09 | Halozyme Therapeutics, Inc. HALO | CEO, President | 6,000 0.0056% | $5.84 | $35,040 | +41.94% | ||
| 2008-03-20 | Sale | Halozyme Therapeutics, Inc. HALO | VP and Chief Scientific Off. | 230,000 0.273% | $6.06 | $1.39M | -13.65% | |
| 2007-12-20 | Sale | Halozyme Therapeutics, Inc. HALO | VP and Chief Scientific Off. | 9,137 0.0123% | $7.00 | $63,959 | -18.55% | |
| 2007-11-21 | Sale | Halozyme Therapeutics, Inc. HALO | VP and Chief Scientific Off. | 10,000 0.0136% | $7.62 | $76,246 | -21.03% | |
| 2007-11-20 | Sale | Halozyme Therapeutics, Inc. HALO | VP and Chief Scientific Off. | 11,700 0.0157% | $7.87 | $92,075 | -23.83% | |
| 2007-10-25 | Sale | Halozyme Therapeutics, Inc. HALO | VP and Chief Scientific Off. | 15,000 0.0203% | $9.03 | $135,377 | -29.29% | |
| 2007-10-24 | Sale | Halozyme Therapeutics, Inc. HALO | VP and Chief Scientific Off. | 15,000 0.02% | $8.98 | $134,761 | -29.91% | |
| 2007-09-27 | Sale | Halozyme Therapeutics, Inc. HALO | VP and Chief Scientific Off. | 15,000 0.0195% | $8.90 | $133,563 | -26.2% | |
| 2007-09-26 | Sale | Halozyme Therapeutics, Inc. HALO | VP and Chief Scientific Off. | 15,000 0.0196% | $9.06 | $135,864 | -27.01% | |
| 2007-08-30 | Sale | Halozyme Therapeutics, Inc. HALO | VP and Chief Scientific Off. | 15,000 0.0199% | $8.45 | $126,752 | -20.8% | |
| 2007-08-29 | Sale | Halozyme Therapeutics, Inc. HALO | VP and Chief Scientific Off. | 15,000 0.0192% | $8.28 | $124,185 | -21.93% | |
| 2007-08-02 | Sale | Halozyme Therapeutics, Inc. HALO | VP and Chief Scientific Off. | 12,601 0.0158% | $8.01 | $100,951 | -20.71% | |
| 2007-08-01 | Sale | Halozyme Therapeutics, Inc. HALO | VP and Chief Scientific Off. | 30,000 0.0394% | $8.04 | $241,300 | -17.35% | |
| 2007-07-06 | Sale | Halozyme Therapeutics, Inc. HALO | VP & Chief Scientific Ofcr | 25,000 0.0322% | $9.82 | $245,553 | -33.53% | |
| 2007-07-05 | Sale | Halozyme Therapeutics, Inc. HALO | VP & Chief Scientific Ofcr | 15,000 0.0194% | $9.62 | $144,267 | -31.91% | |
| 2007-06-07 | Sale | Halozyme Therapeutics, Inc. HALO | VP and Chief Scientific Off. | 40,000 0.0546% | $10.49 | $419,508 | -30.49% |